Jeff Yass’s Jaguar Health JAGX Stock Holding History

Jeff Yass’s Portfolio JAGX Stock Details JAGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Hold	–	-$2.69K	–	12743
2023 Q4	–	Hold	–	–	–	12161
2023 Q3	–	Hold	–	–	–	11797
2023 Q2	–	Hold	–	–	–	11769
2023 Q1	–	Hold	–	–	–	12186
2022 Q4	–	Hold	–	–	–	12053
2022 Q3	–	Hold	–	–	–	12801
2022 Q2	–	Hold	–	–	–	12343
2022 Q1	–	Hold	–	–	–	12215
2021 Q4	–	Hold	–	–	–	12727
2021 Q3	–	Hold	–	–	–	10131
2021 Q2	–	Hold	–	–	–	11900
2021 Q1	–	Hold	–	–	–	10744

Other funds holding JAGX

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

LSA

Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Jeff Yass's JAGX Position: Q1 2025 in Review

Jeff Yass sold out of Jaguar Health (JAGX) in Q1 2025, closing a stake of 14 shares — an estimated $11.6K sold.

Jeff Yass first reported a position in JAGX in Q1 2024 and held it in 2 quarters. The position peaked at $14.1K in Q1 2024. 4 funds tracked by Wall St. Rank hold JAGX as of Q1 2025.

Jeff Yass reported no remaining Jaguar Health position as of Q1 2025 after selling out during the quarter.
Jeff Yass sold 14 Jaguar Health shares in Q1 2025, an estimated $11.6K.
Jeff Yass first reported a position in Jaguar Health in Q1 2024 and held it in 2 quarters.
Jeff Yass's Jaguar Health position peaked at $14.1K in Q1 2024.
4 funds tracked by Wall St. Rank held Jaguar Health as of Q1 2025.

Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.